Hansen Medical, Inc. (NASDAQ: HNSN) 30.6% LOWER; sees Q2 sales of $3.1-$3.3 million, versus the consensus of $8.77 million. Also ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE